Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Blocking miR-27a increases sheep hair follicle stem cell growth and decreases cell death, which could help improve wool quality and treat hair loss.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Infections during JAK inhibitor treatment for alopecia areata are usually manageable and rarely stop treatment permanently.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Afatinib often causes skin problems that need proactive management.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Baricitinib helps with early hair regrowth in people with alopecia areata.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Reducing gefitinib dosage improved hair loss, but scarring remained.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.